Search the Newsreel

Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer

Ascentage Pharma has announced the appointments of Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer. These appointments aim to strengthen the company's global business development and establish a dedicated commercial organization in the United States. Both executives will …

ERASCA DEADLINE: ROSEN, REGARDED INVESTOR COUNSEL, Encourages Erasca, Inc. Investors to Secure Counsel Before Important August 10 Deadline in Securities Class Action – ERAS

NEW YORK, Aug. 02, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the “Class Period”), of the important August …

Banca Monte Dei Paschi Siena Aktie: Kurs, Chart, Kursziel & Dividende

Boise Cascade (BCC) Reports Earnings Tomorrow: What To Expect

Boise Cascade (BCC) is set to announce its earnings tomorrow. The company beat revenue expectations last quarter, reporting $1.50 billion, and analysts expect a 1.8% year-on-year revenue growth this quarter, a reversal from last year's decrease. Despite some peers outperforming, Boise Cascade has seen …

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Receives Average Rating of "Buy" from Analysts

Arrowstreet Capital Limited Partnership Trims Stake in Ardmore Shipping Corporation $ASC

Arrowstreet Capital Limited Partnership significantly reduced its stake in Ardmore Shipping Corporation (NYSE:ASC) by 40.4% in the first quarter, now owning 495,816 shares worth $7.56 million. Despite this, other institutional investors increased their positions, and analysts generally maintain a "Moderate Buy" rating with a …

LeMaitre (LMAT) Reports Earnings Tomorrow: What To Expect

LeMaitre (LMAT) Reports Earnings Tomorrow: What To Expect Medical device company LeMaitre Vascular (NASDAQ:LMAT) will be announcing earnings results this Tuesday after market close. Here's what you need to know. LeMaitre met analysts' revenue expectations last quarter, reporting revenues of $66.55 million, up 11.2% …

Banca Monte Dei Paschi Siena Aktie: Banco-BPM-Fusionsgespräche beendet

Athabasca Oil (TSX:ATH) Is Down 5.5% After Q2 Revenue Dip But Higher Output Guidance

Ascentage Pharma Group Number of Employees 2026 | Employee Count & Headcount Data

Ascentage Pharma Group International Co., Ltd. (6855) has approximately 760 employees worldwide as of March 2026, marking a 19.2% growth since 2023. The company, headquartered in Suzhou, China, with major operations in China and the United States, is actively hiring, with 5 active job …

LeMaitre Vascular (LMAT) Holds A 15% Undervalued View, Is The Stock Fully Priced?

LeMaitre Vascular (LMAT) closed at $101.32 on July 29, 2026, and is considered 15% undervalued with a fair value of $118.75 based on analyst forecasts and a strong product pipeline. However, its P/E ratio of 37.1x screens as expensive against the market and industry, …

CapitaLand Ascott Trust flags S$200m loan covenant tied to REIT manager

ASND News & Events

This page provides a comprehensive overview of recent news, events, and price alerts related to Ascendis Pharma (ASND). It includes various news articles detailing clinical trial data releases, index inclusions, and financial results. The events section highlights analyst notes and new data presentations for …

ASND Stock News Today | Earnings, Events & Price Alerts

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Average Rating of "Moderate Buy" by Brokerages

LeMaitre Vascular, Inc. (NASDAQ:LMAT) has received an average "Moderate Buy" rating from brokerages, with an average 12-month price target of $112.60. The company recently surpassed quarterly EPS expectations and saw an 11.1% revenue increase. Despite insider stock sales totaling approximately $5.9 million, institutional investors …

MAS.GM Bond Profile — Key Metrics

This article provides a bond profile for Masco Corporation (MAS.GM), detailing key metrics such as its 0% coupon rate, maturity date of July 20, 2031, and an issue date of December 20, 2004. It also includes a brief description of Masco Corp.'s business, which …

Ascentage Pharma Group International Revenue Breakdown – HKEX:6855

Ascentage Pharma Group International (HKEX:6855) generated 638.92 million HKD last year, with its top-performing segment, Therapies for Hematological Malignancies, contributing 541.47 million HKD. The majority of this revenue, 622.65 million HKD, came from China. The article provides a breakdown of the company's revenue by …

Ascendis Pharma A/S (ASND) Institutional Confidence

Ascendis Pharma A/S (ASND) has an institutional shareholding score of 10.00, placing it first in the Biotechnology & Medical Research industry. The institutional shareholding proportion is 111.42%, a slight decrease of 4.32% quarter-over-quarter. ETHSX is the largest institutional shareholder, holding 132.15K shares, which represents …

Athabasca Oil (TSX:ATH) Stock Looks Cheap But Margins Keep Tightening

Masco Corp Lobbyists, 2021

This article details Masco Corp's lobbying activities in 2021, including their total spending, the number of lobbyists employed, and the firms involved. It identifies three named lobbyists for Masco Corp in 2021, with one in-house and two from the Laurin Baker Group. The content …

BlackRock, Inc. Reduces Ardmore Shipping Corp (ASC) Stake -- Sha

BlackRock, Inc. has significantly reduced its stake in Ardmore Shipping Corp (ASC) by selling 986,987 shares, representing a 31.04% trim of its holdings. This transaction, executed at $14.01 per share, occurred on June 30, 2026, and the stock has since appreciated by 24.13%. Ardmore …

Boise Cascade (BCC) Stock Looks Rich After An 83% Five Year Gain

Boise Cascade (BCC) has seen an 83.3% gain over the past five years, but its current valuation presents a mixed picture. A Discounted Cash Flow (DCF) analysis suggests the stock is overvalued by 11.7%, while an earnings-based P/E multiple indicates it might be undervalued. …

Is Boise Cascade’s Higher Dividend a Clue to Its Evolving Capital Allocation Strategy (BCC)?

Boise Cascade's Board of Directors previously approved a 5% increase in its quarterly dividend to US$0.23 per share, payable on September 16, 2026, to shareholders of record as of September 1, 2026. This higher regular dividend underscores the company's focus on returning cash to …

ERAS DEADLINE: The Gross Law Firm Reminds Erasca, Inc. Investors of Upcoming Securities Class Action Deadline

The Gross Law Firm is reminding investors of Erasca, Inc. (NASDAQ: ERAS) about an upcoming deadline for a securities class action lawsuit. Shareholders who purchased ERAS shares between January 14, 2025, and April 26, 2026, are encouraged to contact the firm regarding potential lead …

Robbins LLP Reminds Erasca, Inc. Investors of the Pending Lead Plaintiff Deadline in the ...

Robbins LLP is reminding investors of Erasca, Inc. (NASDAQ: ERAS) that a class action lawsuit has been filed against the company. The lawsuit alleges that Erasca failed to disclose that it was at risk of violating patent and trade secret protections and that its …

Masco Analysts Slash Their Forecasts After Q2 Results

Masco Corp (NYSE: MAS) reported mixed second-quarter financial results, beating earnings estimates but missing on sales. Following the announcement, Masco raised its full-year 2026 adjusted EPS guidance. Several analysts subsequently adjusted their price targets for the stock, with one downgrading its rating.

Are Consumer Staples Stocks Lagging Burcon NutraScience (BRCNF) This Year?

Investors interested in Consumer Staples stocks should always be looking to find the best-performing companies in the group. Burcon NutraScience Corp (BRCNF) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector …

Should Value Investors Buy Boise Cascade (BCC) Stock?

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong …

Why TerrAscend Corp. stock surged yesterday

Why ASOS (LSE:ASC) And Boohoo (LSE:BOO) Remain On The UK Penny Stock Radar

Ascentage Pharma (NASDAQ: AAPG) CEO ranks No.3 on Medicine Maker 2026 list

Ascentage Pharma's Chairman and CEO, Dr. Dajun Yang, has been recognized on The Medicine Maker Power List 2026, ranking No. 3 in the Small Molecules category. The list honors 60 global leaders driving innovation in drug discovery and development. Dr. Yang's inclusion highlights his …

Masco Earnings Rise as Pricing and Tariff Refunds Lift 2026 Margins

Masco Corporation reported mixed results for Q2 2026, with earnings and margins sharply improved due to pricing, cost savings, and a significant tariff refund, but sales declined. The company's adjusted earnings per share rose 26% year-over-year, beating estimates, while net sales fell 2.9% and …

Precision Trading with Lemaitre Vascular Inc. (LMAT) Risk Zones

This article from Stock Traders Daily provides a detailed analysis of Lemaitre Vascular Inc. (LMAT) focusing on precision trading strategies and risk zones. It highlights near-term strong sentiment, mid-term neutrality, and long-term positive bias, along with specific entry, target, and stop-loss levels for different …

Sei Investments Co. Boosts Stock Holdings in LeMaitre Vascular, Inc. $LMAT

Sei Investments Co. increased its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 30.7% in the first quarter, now holding 136,674 shares valued at $14.92 million. Other

Price to book forward of Erasca, Inc. – NASDAQ:ERAS

This article provides the "Price to book forward" financial metric for Erasca, Inc. (NASDAQ: ERAS). It appears to be a stub or data-focused entry from a financial platform, showing the company's ticker, exchange, and the specific financial value along with its change over a …

Metgasco Secures $5M SA Government Grants for Odin and Vali Appraisal Wells as Quarterly Revenue Falls to $292,450